Metis Biotech Completes China`s First Ai-Enabled Drug Phase III
23 Oct 2025 //
PR NEWSWIRE
Metis Unveils First AI Nanoforge Delivery Platform
29 Sep 2025 //
PR NEWSWIRE
METiS Pharma Appoints Mark Herbert as Chief Business Officer
03 Mar 2025 //
PR NEWSWIRE
METIS Phase 3 Trial Met Primary Endpoint, Demonstrating a Significant Extension
27 Mar 2024 //
BUSINESSWIRE
METiS Announces License Agreement with Evopoint Biosciences
06 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support